BioWorld MedTech

June 16, 2014

TAVR/TAVI Takes Center Stage: Shift toward lower-risk patient pools seen as key growth driver for TAVR

The topic of the transcatheter valve replacement (TAVR) market, also known as transcatheter valve implantation (TAVI), brings to mind the classic Dr. Seuss story, "Oh, the Places You'll Go." Read More

Breakout Labs gives leg up to device firms seeking funding

FDA Advisory Committee: Lutonix comes away with win at advisory for drug-coated balloon

MDD's Stock Watch

Agreements/contracts: PerkinElmer to distribute Sofie PET technology

World in Review: Biotronik publishes the results from PEACE 1 all-comers registry

Financings: Envision prices 2022 note offering at $750 million, up from $650 million

Briefly Noted

Product briefs

People in Places

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for Nov. 27, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for November 27, 2024.

Illustration of man holding magnifying glass to human body model showing muscle anatomy

In muscular dystrophies, gene therapies race the clock

BioWorld

Since the isolation of the gene that causes Duchenne muscular dystrophy (DMD), scientists have progressed in understanding the mechanisms that lead to muscular...

AI-generated illustration of heart and metabolic impact

Bridgebio, with FDA approval, faces Pfizer in ATTR

BioWorld

With the U.S. FDA approval of Attruby (acoramidis) for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), Bridgebio Pharma Inc. is taking on an industry...

‘Evo’ AI can design complete genomes

BioWorld Science

The development of new machine learning tools like Alphafold and Rfdiffusion has allowed scientists to predict the structure of proteins and design them for drug...